Clinical Trial Update: A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

This completed Phase 1 trial assessed whether Rifampin changes the pharmacokinetics of trabectedin in patients with advanced malignancies to evaluate potential …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Malignant Neoplasm

Drugs mentioned

• RIFAMPIN (RIFAMPIN)
• Trabectedin (trabectedin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Neoplasm Metastases | Phase 1 | Status: COMPLETED